We focus on peri-operative management of patients, integrate industry resources, bring forth commercial modes to play their synergistic effect, develop innovative drug product lines for preoperative, intraoperative and postoperative management of patients, and so create a closed loop for peri-operative treatment business covering "accurate diagnosis - precise surgery - elaborate treatment".
l The first and only lymph node tracing agent for thyroid cancer approved by NMPA, Mitoxantrone Hydrochloride Injection for Lymph Node Tracing (Futashu®)
l Establishing an extensive academic resource platform for peri-operative treatment
l Creating a self-operated academic promotion and distributing team